CRI Announces Spring Knowledge Network Summit
These are unprecedented times for healthcare in America. The Affordable Care Act is dramatically changing the way healthcare providers are paid, with reimbursement shifting from payment for services to payment for quality and outcomes. Whether healthcare providers are ready or not, healthcare is moving to a fundamentally different paradigm. read more
CRI Helps Individuals with Serious Mental Illness Quit Smoking
David Ayer, PhD, director of clinical research, and other investigators with Massachusetts General Hospital and Harvard Medical School in Boston, conducted a randomized clinical trial that showed the antismoking drug varenicline (Chantix, Pfizer Inc) boosts quit rates in smokers with serious mental illness. The trial was conducted at 10 community mental health centers, including a Centerstone site in Indiana, in the United States. The study was led by Anne Eden Evins, MD, MPH, of Massachusetts General Hospital, and published in the January 8 issue of JAMA.
Fall Knowledge Network Summit Boasts Record Attendance
CRI recently hosted its 9th Knowledge Network Summit at Loews Vanderbilt Hotel in Nashville, TN. The two-day event featured an inspiring video that provided an overview of CRI and 16 leading experts and supporters in the field of behavioral health. The Summit attracted the largest attendance in the five-year history of the event. From demonstrations of Google Glass to Enlighten Analytics, the event was steeped in technology talks. A highlight of the event was a one-on-one discussion between CRI CEO Dr. Tom Doub and Chief Scientist of Cloudera, Jeff Hammerbacher. Other panelists and speakers included … read more
Clinical Research Update
In fiscal year 2013, CRI’s clinical research office facilitated 19 ongoing and 11 new studies that involved 4,473 study participants. Research projects conducted at Centerstone clinics/sites involved 27 investigators located at 18 institutions including Indiana, Vanderbilt, Harvard, and Northwestern universities.